Clinical Trials Sponsored by Capso Vision, Inc.

Total 612 results

Sirion Therapeutics, Inc.

Completed

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis

Panuveitis | Uveitis
Fusion Pharmaceuticals Inc.

Recruiting

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) (AlphaBreak)

Metastatic Castration-resistant Prostate Cancer

United States
Biomea Fusion Inc.

Recruiting

A Phase 1, Study of BMF-500 in Adults With Acute Leukemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Mixed-Phenotype Leukemia

United States
Biomea Fusion Inc.

Recruiting

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

Lymphoma | Lymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Cancer | Progression | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Plasma Cell Myeloma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Refractory | Myeloma, Plasma-Cell | Myelomatosis | Acute Mixed-Phenotype...

United States, Spain, Netherlands, Greece, Italy
Eirion Therapeutics Inc.

Active, not recruiting

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Crow's Feet | Lateral Canthal Lines, LCL

United States
Fusion Pharmaceuticals Inc.

Terminated

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Breast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Liver Cancer | Bladder Carcinoma | Susceptible FGFR3 Genetic Alterations | FGFR3 | FGFR3 Overexpression | FGFR3 Receptor | FGFR3 Protein Overexpression

United States, Australia
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Crow's Feet | Lateral Canthal Lines, LCL

United States
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-207

Lateral Canthal Lines | Crow's Feet

United States
ReVision Optics, Inc.

Completed

A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near Vision in Presbyopic Patients

Presbyopia

United States
Sirion Therapeutics, Inc.

Completed

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)

Inflammation

United States
Sirion Therapeutics, Inc.

Completed

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)

Dry Eye Syndromes

United States
Sirion Therapeutics, Inc.

Completed

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)

Inflammation

United States
Sirion Therapeutics, Inc.

Completed

Study of Difluprednate in the Treatment of Uveitis

Uveitis

United States
Sirion Therapeutics, Inc.

Completed

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

Inflammation
Sirion Therapeutics, Inc.

Completed

Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation

Inflammation
Johnson & Johnson Vision Care, Inc.
Foresight Regulatory Strategies, Inc.

Completed

In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact Lens

Astigmatism
Johnson & Johnson Vision Care, Inc.
Foresight Regulatory Strategies, Inc.

Completed

Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear

Astigmatism
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Primary Open-angle Glaucoma

United States
Advanced Vision Care
Clinical Research Consultants, Inc.

Recruiting

Accuracy of IOLMASTER 700 Total Keratometry (TK)

Cataract | Myopia | Hyperopia

United States
Johnson & Johnson Vision Care, Inc.
Eurolens Research

Completed

The Clinical Evaluation of Two Daily Disposable Contact Lenses

Myopia

United Kingdom
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson

Terminated

Silicone Hydrogel Contact Lenses on Low Astigmatism in Japan

Refractive Error | Astigmatism | Myopia

Japan
Kubota Vision Inc.
China Medical University Hospital

Not yet recruiting

Electronic Spectacles Versus Low Dose Atropine in Young Myopes

Myopia
iVeena Delivery Systems, Inc.
Codet Vision Institute

Completed

Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients

Keratoconus | Corneal Ectasia

Mexico
Vision Service Plan
Foresight Regulatory Strategies, Inc.

Completed

PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses (PAVES)

Refractive Errors

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride (SEATTLE)

Geographic Atrophy

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome

Dry Eye Syndrome

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

Geographic Atrophy | Dry Age-related Macular Degeneration

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

Dry Eye | Keratoconjunctivitis Sicca

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye

Dry Eye Syndromes | Keratoconjunctivitis Sicca

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects

Healthy

United States
Carolina Eyecare Physicians, LLC
Science in Vision; Imprimis Pharmaceuticals, Inc.

Completed

Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen

Cataract

United States
Viron Therapeutics Inc

Terminated

Serp-1 for the Treatment of Acute Coronary Syndrome

Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis

United States, Canada
Kubota Vision Inc.
Food and Drug Administration (FDA)

Completed

Safety and Efficacy of Emixustat in Stargardt Disease (SeaSTAR)

Stargardt Disease

United States, United Kingdom, Germany, Spain, Brazil, Canada, Denmark, France, Italy, Netherlands, South Africa
Johnson & Johnson Vision Care, Inc.
Visioncare Research Ltd.

Completed

Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens

Myopia

United States
Johnson & Johnson Vision Care, Inc.
Visioncare Research Ltd.

Completed

Clinical Performance Comparison of Two Contact Lenses

Myopia

United States
Johnson & Johnson Vision Care, Inc.
Visioncare Research Ltd.

Completed

Clinical Evaluation of Two Toric Contact Lenses in Current Non-toric Lens Users

Astigmatism

United Kingdom
Starr Muscle
Ohr Pharmaceutical Inc.

Withdrawn

Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)

Diabetic Retinopathy

United States
Johnson & Johnson Vision Care, Inc.
University of Manchester

Completed

A Comparison of Two Daily Disposable Contact Lenses

Myopia

United Kingdom
Johnson & Johnson Vision Care, Inc.
Visioncare Research Ltd.

Completed

A Comparison of Two Daily Disposable Contact Lenses.

Refractive Error | Myopia

United Kingdom
Johnson & Johnson Vision Care, Inc.
Visioncare Research Ltd.

Completed

Evaluation of Orientation and Visual Acuity of Four Toric Soft Contact Lenses When Head is Tilted at 90 Degrees

Astigmatism

United Kingdom
Johnson & Johnson Vision Care, Inc.
Visioncare Research Ltd.

Completed

A Comparison of Daily Disposable Contact Lenses.

Myopia

United Kingdom
Iworks Laser and Vision Center
Ocular Therapeutix, Inc.

Completed

Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL. (DEXTENZA)

Cataract

United States
Acuity Polymers, Inc.
Andre Vision and Device Research

Completed

Clinical Evaluation of Acuity 200 (Fluoroxyfocon A) RGP Contact Lens (Acuity 200)

Refractive Errors

United States
University of Virginia
Johnson & Johnson Vision Care, Inc.

Completed

Evaluating and Improving Functional Driving Vision of Patients With Astigmatism

Astigmatism

United States
Johnson & Johnson Vision Care, Inc.
University of Manchester

Completed

Clinical Performance of a New Daily Disposable Contact Lens Worn in a Neophyte Population.

Refractive Error | Myopia

United Kingdom
Johnson & Johnson Vision Care, Inc.
Visioncare Research Ltd.

Completed

Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients

Presbyopia

United States
Johnson & Johnson Vision Care, Inc.
Ohio State University

Completed

Assessment of Daily Disposable Silicone Hydrogel Lens Wear

Myopia

United States
Johnson & Johnson Vision Care, Inc.
University of Manchester

Completed

Clinical Performance of a New Daily Disposable Contact Lens Worn in an Established Contact Lens Wearing Population

Refractive Error | Myopia

Canada
Johnson & Johnson Vision Care, Inc.
University of Manchester

Completed

Effect of Eye Movement on Toric Lens Orientation and Visual Acuity

Astigmatism

United Kingdom
University of Miami
Johnson & Johnson Vision Care, Inc.

Completed

Characterization of the Edge of Soft Contact Lens and Its Interaction With Ocular Surface

Healthy

United States

Clinical Trials Sponsored by Capso Vision, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations